CHAMPIONS ONCOLOGY, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Champions Oncology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Champions Oncology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending October 31, 2024 was $728K.
  • Champions Oncology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending October 31, 2024 was -$622K, a 93.5% increase year-over-year.
  • Champions Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$7.3M, a 36.8% decline from 2022.
  • Champions Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$5.34M, a 1074% decline from 2021.
  • Champions Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $548K, a 51.4% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$622K $728K +$2.8M Aug 1, 2024 Oct 31, 2024 10-Q 2024-12-16
Q2 2024 -$3.42M $1.31M +$3.88M May 1, 2024 Jul 31, 2024 10-Q 2024-12-16
Q1 2024 -$7.3M -$133K +$2.43M +94.8% Feb 1, 2024 Apr 30, 2024 10-Q 2024-09-13
Q4 2023 -$9.73M -$2.53M -$91K -3.73% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-15
Q3 2023 -$9.64M -$2.07M -$2.06M -12844% Aug 1, 2023 Oct 31, 2023 10-Q 2024-12-16
Q2 2023 -$7.58M -$2.57M -$2.25M -704% May 1, 2023 Jul 31, 2023 10-Q 2024-12-16
Q1 2023 -$5.34M -$2.56M -$2.22M -644% Feb 1, 2023 Apr 30, 2023 10-K 2024-07-19
Q4 2022 -$3.12M -$2.44M -$3.23M -410% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-15
Q3 2022 $108K -$16K -$293K -106% Aug 1, 2022 Oct 31, 2022 10-Q 2024-03-15
Q2 2022 $401K -$319K -$147K -85.5% May 1, 2022 Jul 31, 2022 10-Q 2024-03-15
Q1 2022 $548K -$344K +$329K +48.9% Feb 1, 2022 Apr 30, 2022 10-K 2023-07-24
Q4 2021 $219K $787K -$172K -17.9% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-16
Q3 2021 $391K $277K +$276K Aug 1, 2021 Oct 31, 2021 10-Q 2023-03-16
Q2 2021 $115K -$172K -$247K -329% May 1, 2021 Jul 31, 2021 10-Q 2023-03-16
Q1 2021 $362K -$673K +$1.16M +63.3% Feb 1, 2021 Apr 30, 2021 10-K 2022-07-22
Q4 2020 -$799K $959K +$884K +1179% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 -$1.68M $1K* -$306K Aug 1, 2020 Oct 31, 2020 10-Q 2022-03-15
Q2 2020 -$1.38M $75K +$716K May 1, 2020 Jul 31, 2020 10-Q 2022-03-15
Q1 2020 -$2.09M -$1.83M -$1.58M -625% Feb 1, 2020 Apr 30, 2020 10-K 2021-07-26
Q4 2019 -$512K $75K +$444K Nov 1, 2019 Jan 31, 2020 10-Q 2021-09-13
Q3 2019 -$956K $307K +$40K +15% Aug 1, 2019 Oct 31, 2019 10-Q 2021-03-15
Q2 2019 -$996K -$641K -$1.12M -233% May 1, 2019 Jul 31, 2019 10-Q 2021-03-15
Q1 2019 $128K -$253K +$379K +60% Feb 1, 2019 Apr 30, 2019 10-K 2020-07-28
Q4 2018 -$251K -$369K -$293K -386% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-16
Q3 2018 $42K $267K +$361K Aug 1, 2018 Oct 31, 2018 10-Q 2020-03-16
Q2 2018 -$319K $483K +$1.16M May 1, 2018 Jul 31, 2018 10-Q 2020-03-16
Q1 2018 -$1.48M -$632K +$1.79M +73.9% Feb 1, 2018 Apr 30, 2018 10-K 2019-07-29
Q4 2017 -$3.27M -$76K +$1.33M +94.6% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-18
Q3 2017 -$4.6M -$94K +$410K +81.3% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-17
Q2 2017 -$5.01M -$674K +$1.87M +73.5% May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q1 2017 -$6.88M -$2.42M +$147K +5.73% Feb 1, 2017 Apr 30, 2017 10-K 2018-07-30
Q4 2016 -$7.03M -$1.41M +$1M +41.6% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-19
Q3 2016 -$8.03M -$504K +$2.04M +80.2% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-15
Q2 2016 -$10.1M -$2.55M +$367K +12.6% May 1, 2016 Jul 31, 2016 10-Q 2017-09-14
Q1 2016 -$10.4M -$2.57M +$1.13M +30.4% Feb 1, 2016 Apr 30, 2016 10-K 2017-07-28
Q4 2015 -$11.6M -$2.41M +$404K +14.3% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-17
Q3 2015 -$12M -$2.55M +$530K +17.2% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-14
Q2 2015 -$12.5M -$2.91M +$635K +17.9% May 1, 2015 Jul 31, 2015 10-Q 2016-09-14
Q1 2015 -$13.1M -$3.7M -$1.42M -62% Feb 1, 2015 Apr 30, 2015 10-K 2016-07-29
Q4 2014 -$11.7M -$2.82M -$2.24M -391% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-16
Q3 2014 -$9.48M -$3.08M -$760K -32.8% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-15
Q2 2014 -$8.72M -$3.55M -$1.32M -59% May 1, 2014 Jul 31, 2014 10-Q 2015-09-11
Q1 2014 -$7.41M -$2.28M -$239K -11.7% Feb 1, 2014 Apr 30, 2014 10-K 2015-07-29
Q4 2013 -$7.17M -$574K +$416K +42% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-17
Q3 2013 -$7.58M -$2.32M -$344K -17.4% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-15
Q2 2013 -$7.24M -$2.23M -$909K -68.7% May 1, 2013 Jul 31, 2013 10-Q 2014-09-12
Q1 2013 -$6.33M -$2.04M +$513K +20.1% Feb 1, 2013 Apr 30, 2013 10-K 2014-07-28
Q4 2012 -$6.84M -$990K +$729K +42.4% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-14
Q3 2012 -$7.57M -$1.97M +$375K +16% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-13
Q2 2012 -$7.95M -$1.32M +$714K +35.1% May 1, 2012 Jul 31, 2012 10-Q 2013-09-13
Q1 2012 -$8.66M -$2.56M +$186K +6.78% Feb 1, 2012 Apr 30, 2012 10-K 2013-07-26
Q4 2011 -$8.85M -$1.72M -$1.3M -314% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-13
Q3 2011 -$7.54M -$2.35M -$2.3M -4250% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-13
Q2 2011 -$5.25M -$2.04M -$1.45M -245% May 1, 2011 Jul 31, 2011 10-Q 2012-09-12
Q1 2011 -$3.8M -$2.74M Feb 1, 2011 Apr 30, 2011 10-K 2012-07-18
Q4 2010 -$415K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-14
Q3 2010 -$54K Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-14
Q2 2010 -$591K May 1, 2010 Jul 31, 2010 10-Q 2011-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.